Serum apolipoprotein B100 concentrations in obese Holstein heifers

被引:0
|
作者
Civelek, T
Çelik, HA
Birdane, FM
Yaggi, A
Pancarci, SM
Kabu, M
机构
[1] Kocatepe Univ, Fac Vet Med, Dept Internal Med, Afyon, Turkey
[2] Kocatepe Univ, Fac Vet Med, Dept Obstet & Gynecol, Afyon, Turkey
[3] Kocatepe Univ, Fac Vet Med, Dept Hist, Afyon, Turkey
[4] Kafkas Univ, Fac Vet Med, Dept Obstet & Gynecol, Kars, Turkey
关键词
fatty liver; apolipoprotein B100; obesity; heifer;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The purpose of this study was to examine the changes of serum apolipoprotein B100 (apo B100) concentrations and to evaluate the liver steatosis in obese Holstein heifers. In this study, 10 clinically healthy (with body condition scores (BCS) comprised between 2.75-3.50) and 10 obese (with BCS of 5), Holstein heifers were used. Serum concentrations of apo B100 were assayed by single radial immunodiffusion method. Hepatic biopsy samples, were obtained front liver under local anesthesia with percutaneous biopsy needle for histopathological examination. Our results indicated that serum apo B100 concentrations were not significantly decreased (P = 0.39) in the obese heifers. and the degree of fill infiltration in liver was comparable to controls. It was concluded that the fatty liver disease was absent ill the obese heifers and the changes in apo B100 concentrations should be carefully evaluated together with hepatic biopsy analysis.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 50 条
  • [31] Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein (a)
    Yeang, Calvin
    Hung, Ming-Yow
    Byun, Young-Sup
    Clopton, Paul
    Yang, Xiaohong
    Witztum, Joseph L.
    Tsimikas, Sotirios
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (03) : 594 - 603
  • [32] Ubiquitin-proteasome-dependent degradation of apolipoprotein B100 in vitro
    Sakata, N
    Dixon, JL
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1437 (01): : 71 - 79
  • [33] Detection of apolipoprotein B100 early conformational changes during oxidation
    Krisko, Anita
    Stjepanovic, Goran
    Pifat, Greta
    Ruysschaert, Jean-Marie
    Goormaghtigh, Erik
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (11): : 2923 - 2930
  • [34] The molecular mechanism for the genetic disorder familial defective apolipoprotein B100
    Borén, J
    Ekström, U
    Ågren, B
    Nilsson-Ehle, P
    Innerarity, TL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 9214 - 9218
  • [35] Combination of anomalies in apolipoprotein B100 and apolipoprotein CIII affects coronary heart disease risk
    Funke, H
    Gerd, A
    Schulte, H
    Rust, S
    Cheng, S
    Erlich, HA
    CIRCULATION, 1998, 98 (17) : 738 - 738
  • [36] Maternal Apolipoprotein B100 Serum Levels are Diminished in Pregnancies with Intrauterine Growth Restriction and Differentiate from Controls
    Woelter, Manja
    Okai, Charles A.
    Smith, Derek S.
    Russ, Manuela
    Rath, Werner
    Pecks, Ulrich
    Borchers, Christoph H.
    Glocker, Michael O.
    PROTEOMICS CLINICAL APPLICATIONS, 2018, 12 (06)
  • [37] Inflammatory Nuclear Factor κB Activation Promotes Hepatic Apolipoprotein B100 Secretion
    Tsai, Julie W.
    Zhang, Rianna
    Qiu, Wei
    Su, Qiaozhu
    Naples, Mark
    Adeli, Khosrow
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E33 - E33
  • [38] Relationships of apolipoprotein B100 with the metabolic syndrome in Type 2 diabetes mellitus
    Relimpio, F
    Losada, F
    Pumar, A
    Mangas, MA
    Morales, F
    Astorga, R
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 57 (03) : 199 - 207
  • [39] The structure of apolipoprotein B100 from human low-density lipoprotein
    Zachary T. Berndsen
    C. Keith Cassidy
    Nature, 2025, 638 (8051) : 836 - 843
  • [40] Degradation of apolipoprotein B100 by ubiquitin-proteasome pathway in vitro.
    Sakata, N
    Dixon, JL
    FASEB JOURNAL, 1998, 12 (04): : A126 - A126